Business Description
Vital KSK Holdings Inc
ISIN : JP3778280002
Total Employee Number:
5,240Compare
Compare
Traded in other countries / regions
3151.Japan4GX.GermanyVKSKF.USA IPO Date
2025-12-16Description
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.39 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 0.43 | |||||
Interest Coverage | 59.24 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.64 | |||||
Beneish M-Score | -2.35 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.2 | |||||
3-Year EBITDA Growth Rate | 13.4 | |||||
3-Year EPS without NRI Growth Rate | 15.1 | |||||
3-Year FCF Growth Rate | 63.4 | |||||
3-Year Book Growth Rate | 8.2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 64.39 | |||||
9-Day RSI | 59.37 | |||||
14-Day RSI | 57 | |||||
3-1 Month Momentum % | 5.03 | |||||
6-1 Month Momentum % | 8.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.06 | |||||
Quick Ratio | 0.88 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 21.83 | |||||
Days Sales Outstanding | 74.95 | |||||
Days Payable | 114.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.34 | |||||
3-Year Dividend Growth Rate | 21.5 | |||||
Forward Dividend Yield % | 4.56 | |||||
5-Year Yield-on-Cost % | 10.93 | |||||
3-Year Average Share Buyback Ratio | 2.2 | |||||
Shareholder Yield % | 5.33 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 8.12 | |||||
Operating Margin % | 0.66 | |||||
Net Margin % | 1.21 | |||||
EBITDA Margin % | 2.56 | |||||
FCF Margin % | -0.07 | |||||
OCF Margin % | 0.76 | |||||
ROE % | 6.75 | |||||
ROA % | 2.32 | |||||
ROIC % | 2.05 | |||||
3-Year ROIIC % | 1.03 | |||||
ROC (Joel Greenblatt) % | 23.25 | |||||
ROCE % | 9.09 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 10.24 | |||||
PE Ratio without NRI | 15.15 | |||||
Shiller PE Ratio | 15.92 | |||||
PEG Ratio | 0.69 | |||||
PS Ratio | 0.12 | |||||
PB Ratio | 0.64 | |||||
Price-to-Tangible-Book | 0.68 | |||||
Price-to-Operating-Cash-Flow | 15.6 | |||||
EV-to-EBIT | 5.21 | |||||
EV-to-EBITDA | 3.86 | |||||
EV-to-Revenue | 0.1 | |||||
EV-to-FCF | -138.5 | |||||
Price-to-GF-Value | 1.18 | |||||
Price-to-Projected-FCF | 1.17 | |||||
Price-to-Median-PS-Value | 1.17 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.61 | |||||
Price-to-Graham-Number | 0.68 | |||||
Earnings Yield (Greenblatt) % | 19.19 | |||||
FCF Yield % | -0.58 | |||||
Forward Rate of Return (Yacktman) % | 18.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vital KSK Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3,460.922 | ||
| EPS (TTM) (€) | 0.866 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 57 | ||
| 14-Day ATR (€) | 0.079358 | ||
| 20-Day SMA (€) | 8.16 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 7.181 - 8.65 | ||
| Shares Outstanding (Mil) | 48.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vital KSK Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vital KSK Holdings Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| JPY 35.000000 Cash Dividend | 2026-09-29 | In 79 days | ||
| JPY 36.000000 Cash Dividend | 2026-03-30 | 7.93 (+0.00%) |
Show
Entries
Vital KSK Holdings Inc Frequently Asked Questions
What is Vital KSK Holdings Inc(FRA:4GX)'s stock price today?
The current price of FRA:4GX is €8.30. The 52 week high of FRA:4GX is €8.65 and 52 week low is €7.18.
When is next earnings date of Vital KSK Holdings Inc(FRA:4GX)?
The next earnings date of Vital KSK Holdings Inc(FRA:4GX) is .
Does Vital KSK Holdings Inc(FRA:4GX) pay dividends? If so, how much?
The Dividend Yield %  of Vital KSK Holdings Inc(FRA:4GX) is 2.34% (As of Today), Highest Dividend Payout Ratio of Vital KSK Holdings Inc(FRA:4GX) was 0.68. The lowest was 0.3. And the median was 0.43. The  Forward Dividend Yield % of Vital KSK Holdings Inc(FRA:4GX) is 4.56%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Vital KSK Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers